康特科技 CAMT 深 沪
已收盘 09-19 16:00:00 美东时间
97.61
-3.540
-3.50%
华盛通- 最 高102.00
- 今 开102.00
- 成交量 34.02万股
- 最 低 97.49
- 昨 收 101.15
- 总市值 44.51亿
- 52周最高 110.73
- 市盈率 静 40.29
- 换手率 0.00%
- 52周最低 47.41
- 委 比 6.56%
- 总股本 4560.32万
- 历史最高 140.50
- 量 比 0.32
- 振 幅 4.46%
- 历史最低 -0.56
- 每 手 1
- 风险率 19.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Camtek Announces $400 Million Convertible Notes Offering
Camtek ( ($CAMT) ) has shared an update. On September 11, 2025, Camtek Ltd. ann...
09-12 04:29
Camtek announces $400M offering of convertible senior notes due 2030
Camtek (NASDAQ:CAMT) announced on Thursday its intention to offer $400 million aggregate principal amount of 0.00% convertible senior notes due 2030 in a proposed private offering. In connection with ...
09-12 04:17
Peering Into Camtek's Recent Short Interest
Camtek's (NYSE:CAMT) short percent of float has risen 7.34% since its last repo...
09-09 04:00
Here's How Much You Would Have Made Owning Camtek Stock In The Last 10 Years
Camtek (NASDAQ:CAMT) has outperformed the market over the past 10 years by 26.9...
09-04 04:15
美股大行评级 | 潜在涨幅345.51%！BTIG上调Syndax Pharmaceuticals目标价至56美元，维持"买入"评级
今日重点评级关注：BTIG：维持Syndax Pharmaceuticals"买入"评级，目标价从43美元升至56美元；花旗：维持Syndax Pharmaceuticals"买入"评级，目标价从46美元升至51美元
08-06 09:30
Jefferies Maintains Buy on Camtek, Raises Price Target to $105
Jefferies analyst Blayne Curtis maintains Camtek (NASDAQ:CAMT) with a Buy and raises the price target from $85 to $105.
08-06 04:54
美股三大指数集体收跌 热门科技股多数下跌
美股三大指数集体收跌，道指跌0.14%，纳指跌0.65%，标普500指数跌0.49%，热门科技股多数下跌，微软、Meta、博通均跌超1%，英伟达跌近1%，英特尔...
08-06 04:00
Camtek shares are trading lower following the release of its Q2 financial results.
Camtek shares are trading lower following the release of its Q2 financial resul...
08-05 21:02
Camtek Sees Q3 Sales $125.000M vs $123.942M Est
Camtek (NASDAQ:CAMT) sees Q3 sales of $125.000 million vs $123.942 million analyst estimate.
08-05 19:31
Camtek Q2 Adj. EPS $0.79, Inline, Sales $123.300M Beat $121.619M Estimate
Camtek (NASDAQ:CAMT) reported quarterly earnings of $0.79 per share which met the analyst consensus estimate. This is a 19.7 percent increase over earnings of $0.66 per share from the same period last year. The company
08-05 19:13
